Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk – A Retrospective Cohort Study
B Schaefer, P Würtinger, A Finkenstedt, V Braithwaite, M Effenberger, A Moschen, A Griesmacher, H Tilg, W Vogel, H Zoller · Zeitschrift für Gastroenterologie · 2016 · Heft 05
Bibliografische Angaben
Zusammenfassung
Ferric carboxymaltose (FCM) and iron isomaltoside 1000 (IIM) allow complete correction of iron deficiency in a single infusion. Recent reports have raised concerns that iron substitution with FCM can induce hypophosphatemia. Gastroenterology clinic patients are at risk of hypophosphatemia due to malabsorption or vitamin D deficiency and are frequently treated with high-dose intravenous iron. The aim of this retrospective study was to assess the prevalence and determinants of iron-induced hypophosphatemia. Five hundred and thirty-nine documents containing the keywords ferric carboxymaltose (FCM) or iron isomaltos…